| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/04/1994 | WO1994013789A3 Oligonucleotides with rna cleavage activity |
| 08/04/1994 | WO1994013785A3 Novel bacillus thuringiensis strains active against lepidopteran and coleopteran pests |
| 08/04/1994 | WO1994012650A3 Activating expression of an amplifying endogenous gene by homologous recombination |
| 08/04/1994 | WO1994012637A3 Novel human amyloid protein precursor homologue and kunitz-type inhibitors |
| 08/04/1994 | WO1994011520A3 Novel plants and processes for obtaining them |
| 08/04/1994 | WO1994005700A3 Methods and reagents to detect and characterize norwalk and related viruses |
| 08/04/1994 | CA2154902A1 Recombinant living subunit vaccine composition and process for its preparation |
| 08/04/1994 | CA2154882A1 Tata-binding protein associated factors, nucleic acids encoding tafs, and methods of use |
| 08/04/1994 | CA2154695A1 Tomato spotted wilt virus |
| 08/04/1994 | CA2154578A1 Oligonucleotide alkylphosphonates and alkylphosphonothioates |
| 08/04/1994 | CA2154576A1 Aprotinin and synergistic combinations thereof with lectins as larvicides against insect pests of agronomic crops, harvested material thereof, and products obtained from the harvested material |
| 08/04/1994 | CA2154468A1 Method for identifying and treating individuals bearing cancer cells that express hla-c-clone 10/mage-1 |
| 08/04/1994 | CA2154363A1 Localization of therapeutic agents |
| 08/04/1994 | CA2154358A1 Integrated oligonucleotides |
| 08/04/1994 | CA2154171A1 Max-interacting proteins and related molecules and methods |
| 08/04/1994 | CA2153802A1 Chimeric selectins as simultaneous blocking agents for component selectin function |
| 08/04/1994 | CA2153793A1 Amidase activity polypeptides; genetic tools and host microorganisms for producing the same |
| 08/04/1994 | CA2153790A1 Human monoclonal antibodies to cytomegalovirus |
| 08/04/1994 | CA2153502A1 Transgenic mammals |
| 08/04/1994 | CA2152676A1 Assay method to rule out rupture of membranes in women at risk for imminent delivery |
| 08/04/1994 | CA2150678A1 Acetyl-coa-carboxylase-gen |
| 08/04/1994 | CA2132871A1 Method for modifying, diagnosing, and screening for igf-i sensitive cell barrier properties |
| 08/04/1994 | CA2132637A1 Icam-related protein |
| 08/03/1994 | EP0609059A2 Nucleotide probes |
| 08/03/1994 | EP0608722A1 Biological screens for detection of herbicides |
| 08/03/1994 | EP0608696A2 Heterologous signal sequences for secretion of insect controlling proteins |
| 08/03/1994 | EP0608546A2 Glia activating factor (GAF), antibodies against it and their uses |
| 08/03/1994 | EP0608532A2 Mechanism-based screen for retinoid X receptor agonists and antagonists |
| 08/03/1994 | EP0608334A1 Sperm surface protein |
| 08/03/1994 | EP0608261A1 Immunoreactive hepatitis c virus polypeptide compositions |
| 08/03/1994 | EP0608260A1 Peptide inhibitors of inflammation mediated by selectins |
| 08/03/1994 | EP0608210A1 Mutagenesis testing using transgenic non-human animals carrying test dna sequences |
| 08/03/1994 | EP0474744B1 Pdgf -alpha- receptor |
| 08/03/1994 | EP0220234B1 EXPRESSION AND DIAGNOSTIC USE OF gag ENCODED PEPTIDES WHICH ARE IMMUNOLOGICALLY REACTIVE WITH ANTIBODIES TO LAV |
| 08/03/1994 | CN1090329A Modified lipolytic enzymes and their use |
| 08/03/1994 | CN1090328A Modified lipolytic enzymes and their use |
| 08/03/1994 | CN1090327A Nucleotide sequence encoding carbamoyl phosphate synthetase II |
| 08/03/1994 | CN1090326A Mammalian receptors for interleukin-10 (IL-10) |
| 08/03/1994 | CN1090325A Pullulanase, microorganisms which produce it, processes for the preparation of this pullulanase and the uses thereof |
| 08/03/1994 | CN1090203A Polypeptide vaccine for aftosa and its preparation |
| 08/02/1994 | US5334711 Synthetic catalytic oligonucleotide structures |
| 08/02/1994 | US5334532 PDGF-B fusion protein, vectors, and host cells for use in production thereof |
| 08/02/1994 | US5334531 Plasmid vector for expression in bacillus and used for cloning the structural gene which codes for the human growth hormone and a method of producing the hormone |
| 08/02/1994 | US5334522 System for isolating and producing new genes, gene products and DNA sequences |
| 08/02/1994 | US5334521 Cloning and characterization of a cardiac adenylyl cyclase |
| 08/02/1994 | US5334520 Production of poly-beta-hydroxybutyrate in transformed escherichia coli |
| 08/02/1994 | US5334515 Method for altering a nucleotide sequence |
| 08/02/1994 | US5334512 Genetic engineering |
| 08/02/1994 | US5334511 Microorganism escherichia contains recombiant DNA, culturing |
| 08/02/1994 | US5334499 Methods of extracting, amplifying and detecting a nucleic acid from whole blood or PBMC fraction |
| 08/02/1994 | US5334394 A core particle with a surface coatings consisting of maltose, cellobiose, trehalose, isomaltose, nystose, maltotriose and nitrocellulose, bonding with immobilized virus cells; aids vaccines |
| 08/02/1994 | CA2113669A1 Monoclonal antibody that distinguishes between phosphorylated and nonphosphorylated histone h1, and uses therefor |
| 08/02/1994 | CA1331157C Method for producing factor viii:c-type proteins |
| 08/02/1994 | CA1331156C Haloarylnitrile degrading gene, its use, and cells containing the gene |
| 08/02/1994 | CA1331155C Baculovirus transfer vectors |
| 08/02/1994 | CA1331154C Proteolytic enzymes |
| 07/27/1994 | EP0608172A1 Phaffia rhodozyma mutants, process for the production of beta-caroten and use of a beta-caroten rich biomass |
| 07/27/1994 | EP0608117A2 Antibodies for mevalonic acid and methods for determination of mevalonic acid |
| 07/27/1994 | EP0608004A2 Human DNA in the diagnosis of retinoblastoma |
| 07/27/1994 | EP0607925A2 Transgenic mammals as models for thrombocytopenia and/or megakaryocyte leukemia |
| 07/27/1994 | EP0607425A1 Epstein-barr virus peptides and antibodies against these peptides |
| 07/27/1994 | EP0607368A1 Fusion protein from feline leukaemia virus gp70 as vaccine |
| 07/27/1994 | EP0607332A1 Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction |
| 07/27/1994 | EP0607309A1 The regulation of systemic immune responses utilizing cytokines and antigens |
| 07/27/1994 | EP0607297A1 Hormone analogs with multiple ctp extensions |
| 07/27/1994 | EP0607247A1 Production of gpa neurotrophic factor |
| 07/27/1994 | EP0607206A1 Composition for inserting nucleic acid complexes into higher eucaryotic cells |
| 07/27/1994 | EP0607178A1 Methods for the selection, separation and fusion of cells |
| 07/27/1994 | EP0549709A4 Probe compositions for chromosome identification and methods |
| 07/27/1994 | EP0544792A4 Novel nucleoside analogs |
| 07/27/1994 | EP0542928A4 Improved non-nucleotide-based linker reagents for oligomers |
| 07/27/1994 | EP0491713B1 Rubella e1 and c peptides |
| 07/27/1994 | EP0461155B1 Improved methods for in vitro dna amplification and genomic cloning and mapping |
| 07/27/1994 | EP0346500B1 Elastase inhibiting polypeptides and process for their preparation by genetic recombination |
| 07/27/1994 | CN1089992A Novel vectors |
| 07/27/1994 | CN1089951A Novel glycoforms of soluble complement receptor 1 |
| 07/26/1994 | US5332808 DNA encoding a ribosome inactivating protein |
| 07/26/1994 | US5332804 High molecular weight human angiogenic basic fibroblast growth factors |
| 07/26/1994 | US5332676 Avipox virus promoter |
| 07/26/1994 | US5332671 Production of vascular endothelial cell growth factor and DNA encoding same |
| 07/26/1994 | US5332668 Protease with low thermostability derived from Mucor pusillus |
| 07/26/1994 | US5332666 Method, system and reagents for DNA sequencing |
| 07/26/1994 | US5332660 Gene encoding aspartic acid secretory proteinase of Candida albicans and a method of using the gene for the detection of Candida albicans |
| 07/26/1994 | US5332658 Recombinant human rotavirus VP7 serotype 4 |
| 07/26/1994 | US5332583 Genetic engineering |
| 07/26/1994 | CA2113981A1 Codon optimized dna sequence for insect toxin aait |
| 07/26/1994 | CA2113979A1 Heterologous signal sequences for secretion of insect controlling proteins |
| 07/26/1994 | CA2087739A1 Putative target for an immunotherapeutic approach to prevent, and stop the neurological and other symptoms of lesch-nyhan syndrome in humans: reconstructed cdna and protein antisense to the human hprt gene |
| 07/26/1994 | CA1330961C Auto-anti-idiotypic monoclonal antibodies to steroid receptors and uses thereof |
| 07/21/1994 | WO1994016332A1 Method for screening catalytic non-enzyme polypeptides and proteins |
| 07/21/1994 | WO1994016108A1 Sensitive nucleic acid sandwich hybridization assays and kits |
| 07/21/1994 | WO1994016106A1 Diagnostic assays and kits for rna using rna binary probes and an rna-directed rna ligase |
| 07/21/1994 | WO1994016105A1 Rna assays using rna binary probes and ribozyme ligase |
| 07/21/1994 | WO1994016103A2 Detection of synthetic oligonucleotides extracted from body fluids or tissues |
| 07/21/1994 | WO1994016101A2 Dna sequencing by mass spectrometry |
| 07/21/1994 | WO1994016096A2 Method to predict active growth of bacteria adhered to a surface |
| 07/21/1994 | WO1994016094A2 Recombinant anti-vla4 antibody molecules |
| 07/21/1994 | WO1994016092A1 Method for producing tagged genes, transcripts, and proteins |
| 07/21/1994 | WO1994016090A1 Method for generating single-stranded dna molecules |
| 07/21/1994 | WO1994016089A1 Viral amplification of recombinant messenger rna in transgenic plants |